RHerlinda Garcia said she became a "whole different person" after her doctor told her she had stage IV breast cancer. The 54-year-old mother of four had gone through a procedure to remove a tumor from her left breast when she got the grim diagnosis.
"When you're told you have stage IV terminal cancer, that's it," she said to CBS affiliate KHOU in Houston. "I put trust in the doctor."
She underwent a grueling eight rounds of chemotherapy over seven months. Then she went to another doctor to treat her anxiety, and he gave her some shocking news: She never had cancer in the first place. One of the nation's top hospitals, M.D. Anderson Cancer Center in Houston, performed additional tests and confirmed that her original diagnosis was false.
"I was happy, but at the same time, I had that anger. The damage had been done," she said.
Medical mistakes this extreme are, fortunately, rare. "In 33 years in medicine, I've never heard of a case like this," said CBS News chief medical correspondent Dr. Jon LaPook. Read more >>
Showing posts with label Cancer. Show all posts
Showing posts with label Cancer. Show all posts
Friday, July 19, 2013
Thursday, June 13, 2013
Supreme Court rules human genes cannot be patented
The Supreme Court ruled Thursday that human genes cannot be patented, a decision with both immediate benefits for some breast and ovarian cancer patients and long-lasting repercussions for biotechnology research.
The decision represents a victory for cancer patients, researchers and geneticists who claimed that a single company's patent raised costs, restricted research and sometimes forced women to have breasts or ovaries removed without sufficient facts or second opinions.
But the court held out a lifeline to Myriad Genetics, the company with an exclusive patent on the isolated form of genes that can foretell an increased genetic risk of cancer. The justices said it can patent a type of DNA that goes beyond extracting the genes from the body.
Justice Clarence Thomas wrote the decision for a unanimous court. "Myriad did not create anything," Thomas said. "To be sure, it found an important and useful gene, but separating that gene from its surrounding genetic material is not an act of invention."
The compromise will not stop other scientists from providing genetic diagnostic testing now that the patent on the two genes themselves has been lifted. That should lead to lower costs and greater access. Read more >>
The decision represents a victory for cancer patients, researchers and geneticists who claimed that a single company's patent raised costs, restricted research and sometimes forced women to have breasts or ovaries removed without sufficient facts or second opinions.
But the court held out a lifeline to Myriad Genetics, the company with an exclusive patent on the isolated form of genes that can foretell an increased genetic risk of cancer. The justices said it can patent a type of DNA that goes beyond extracting the genes from the body.
Justice Clarence Thomas wrote the decision for a unanimous court. "Myriad did not create anything," Thomas said. "To be sure, it found an important and useful gene, but separating that gene from its surrounding genetic material is not an act of invention."
The compromise will not stop other scientists from providing genetic diagnostic testing now that the patent on the two genes themselves has been lifted. That should lead to lower costs and greater access. Read more >>
Monday, December 20, 2010
Drinking water in 35 American cities contains large amounts of likely carcinogen
The study by the Environmental Working Group -- the first nationwide analysis measuring the presence of the chemical in US water systems -- is to be made public on Monday, the daily reported.
The group found hexavalent chromium in the tap water of 31 out of 35 cities sampled. Of those, 25 had levels that exceeded the goal proposed in California, which has been trying aggressively to reduce the chemical in its water supply.
The federal Environmental Protection Agency is considering whether to set a limit for hexavalent chromium in tap water. The agency is reviewing the chemical after the National Institutes of Health, deemed it a "probable carcinogen" in 2008.
Hexavalent chromium has long been known to cause lung cancer when inhaled, and scientists recently found evidence that it causes cancer in laboratory animals when ingested. It has been linked in animals to liver and kidney damage as well as leukemia, stomach cancer and other cancers. More...
Subscribe to:
Posts (Atom)